悦康药业(300033.SZ)在互动平台称,公司多肽药物在国内目前处在临床前研究阶段。
智通财经直播 · 02/21/2022 07:47
悦康药业(300033.SZ)在互动平台称,公司多肽药物在国内目前处在临床前研究阶段。
悦康药业(300033.SZ)在互动平台称,公司多肽药物在国内目前处在临床前研究阶段。
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.